Pharmaceutical services firm revenue up 10% to €191m

First-quarter revenues at pharmaceutical services firm Icon rose 10% year-on-year to $252m (€191m).

The strong increase was attributed to new business wins and contributions from recent investments.

However, net income for the three-month period at the Dublin-headquartered company was slightly down — from $12.8m to $9m — on the corresponding period last year, as were earnings per share, which dipped from 21c in the first quarter of 2011 to 15c for the same period this year.